PARTNERS2: A cluster randomised control trial of a model of collaborative care for people with a diagnosis of bipolar, schizophrenia or other psychoses

Conditions

Schizophrenia, bipolar disorder or psychosis Mental and Behavioural Disorders Schizophrenia, or bipolar, or other types of psychosis

Charley Hobson-Merrett, Julia Frost, Ruth Gwernan‐Jones, Vanessa Pinfold, Michael Clark et al. (14 authors)

PLOS mental health.2024-11-15

10.1371/journal.pmen.0000130

Collaborative care intervention for individuals with severe mental illness: the PARTNERS2 programme including complex intervention development and cluster RCT

Humera Plappert, Richard Byng, Siobhán Reilly, Charley Hobson-Merrett, Jon Allard et al. (33 authors)

Programme Grants for Applied Research2024-07-011 citations

10.3310/yaet7368

Refining a model of collaborative care for people with a diagnosis of bipolar, schizophrenia or other psychoses in England: a qualitative formative evaluation.

Baker E, Gwernan-Jones R, Britten N, Cox M, McCabe C, Retzer A, Gill L, Plappert H, Reilly S, Pinfold V, Gask L, Byng R, Birchwood M.

2019-01-0715 citations

10.1186/s12888-018-1997-z

Interventions

Current interventions as of 22/12/2020: Cluster randomisation is done at GP Practice level. Participant numbers are across four localities: Birmingham and Solihull Mental Health NHS Foundation Trust,

Eligibility

Sex/Gender

All

Age

18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Registered with a participating GP practice 2. Aged 18 years and over 3. A clinical diagnosis of schizophrenia, bipolar, or other types of psychosis schizoaffective disorder (including lifetime and current) or has evidence of chronic psychoses [care clusters 11 and 12]

Exclusion criteria

Exclusion criteria: 1. Inability to understand and complete questionnaires 2. Inability to understand English (or access to translation services) 3. Inability to give informed consent 4. Currently receiving crisis care or care in a secure setting

Design outcomes

Primary

Measure	Time frame
1. Feasibility of the study is measured using practice recruitment rates, patient eligibility rates (via screening logs), patient recruitment rates, patient retention rates 2. Quality of life will be measured at baseline and 10 months using Manchester Short Assessment of Quality of Life (MANSA)	—

Secondary

Measure	Time frame
1. Time Use is measured using modified ONS Time Use Survey (TUS) at baseline and 10 months 2. Recovery is measured using Questionnaire about the Process of Recovery (QPR15) at baseline and 10 months 3. General health status is measured using EuroQol (EQ-5D-5L) at baseline and 10 months 4. Mental wellbeing is measured using Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS ) at baseline and 10 months 5. Capability measured are measured using ICEpop CAPability measure (ICECAP) at baseline and 10 months 6. NHS resource use is measured using the Mental Health Trust records at 10 months 7. Experience of care is measured using BriefINSPIRE at baseline and 10 months 8. Costs of NHS and social care service use is measure using using review of medical records at 10 months	—

Measure

Time frame

1. Time Use is measured using modified ONS Time Use Survey (TUS) at baseline and 10 months 2. Recovery is measured using Questionnaire about the Process of Recovery (QPR15) at baseline and 10 months 3. General health status is measured using EuroQol (EQ-5D-5L) at baseline and 10 months 4. Mental wellbeing is measured using Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS ) at baseline and 10 months 5. Capability measured are measured using ICEpop CAPability measure (ICECAP) at baseline and 10 months 6. NHS resource use is measured using the Mental Health Trust records at 10 months 7. Experience of care is measured using BriefINSPIRE at baseline and 10 months 8. Costs of NHS and social care service use is measure using using review of medical records at 10 months

—

Countries

England, United Kingdom

Outcome results

None listed